Page 42 - Read Online
P. 42

Cangemi et al. Mini-invasive Surg 2022;6:3  https://dx.doi.org/10.20517/2574-1225.2021.99  Page 5 of 13

               Table 1. Timing of PCI in relation to TAVI
                           Advantages              Disadvantages                      Preferred clinical scenario
                Staged pre-  Easier access to coronary arteries   Risk of acute decompensation during PCI   Acute coronary syndrome
                TAVI PCI   Improve coronary flow, preventing   Left main and right coronary artery ostial lesions   Severe left main stem lesions
                           myocardial ischemia during   require special consideration because an implanted   and proximal coronary lesions
                           ventricular pacing      valve can crush the stent frame    Complex coronary artery
                                                   Increase vascular and bleeding complications due to   lesions
                                                   dual antiplatelet therapy          Anatomical consideration
                                                                                      (type of-valve, valve-in-valve
                                                                                      procedure)
                Staged post-  Improve hemodynamic before PCI   Risk of ischemia during TAVI   Intermediate coronary artery
                TAVI PCI   More accurate assessment of the   Cannulation of coronary artery and performing PCI   lesions
                           functional severity of CAD  may be more challenging
                PCI and    Reduction of vascular complications   Increase volume of contrast   Normal kidney function
                concomitant   Reduce costs of hospitalizations   Higher radiation dose   Simple coronary artery
                           No delays in case of rescue/bail-out  Longer duration of the procedure
                                                                                      stenosis
                TAVI
                           strategies if needed
               CAD: Coronary artery disease; PCI: percutaneous coronary intervention; TAVI: transcatheter aortic valve implantation.

























                Figure 2. A concomitant myocardial revascularization and transcatheter aortic valve implantation (TAVI). The aortography performed
                during TAVI procedure showed a double stenosis of right coronary artery confirmed by selective angiography and not revealed by
                computed tomography scan (A). The coronary artery stenosis was very tight; therefore, the percutaneous treatment was performed
                before the TAVI (B). After the percutaneous coronary intervention (PCI), a self-expandable valve was implanted (C).


               after TAVI. The major challenge of performing PCI in TAVI patients is selective cannulation of coronary
               ostia. This is an increasingly important problem given the progressive younger age of candidates for TAVI.
                                 [50]
               A single-center study  identified that 5.3% of TAVR recipients underwent coronary angiography during a
               follow-up of about three years. The authors attributed this low incidence to two possible causes: a Heart
               Team-based pre-TAVR revascularization and a possible reduced recourse to coronary angiography in the
               case of ACS due to the numerous comorbidities of the patients. The main factors that influence engagement
               of coronary ostia in patients with TAVI are divided into three groups: anatomical, related to the prosthesis,
                            [51]
               and procedural . Generally, greater height of the coronary arteries and augmented width of valsalva
               sinuses are associated with easier coronary ostia engagement. In fact, coronary ostia are not covered by
               valve skirt, thus it is not difficult to cannulate the ostium [51,52] . All studies that evaluated the coronary access
               in patients with TAVI demonstrated greater difficulty with Evolut than Sapien prostheses [51,53,54] . The reasons
               are to be found in the different conformation and size of the two main types of valve prostheses currently
                   [51]
               used . The self-expanding valves (Evolut and Portico prostheses) are taller than balloon-expandable valves
               (Sapien prostheses) and extend beyond coronary ostia. Hence, if the neo-commissure of prosthesis is
   37   38   39   40   41   42   43   44   45   46   47